Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: May 18, 2026
Martin Fan 's Stock Ratings
Wedbush Analyst
Martin Fan is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
88.3%
Smart Score
Overall Average Return Percentile
97th
Number of Ratings
34
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2026 | VOR | Buy Now | Vor Biopharma | $14.16 | 27.12% | $15 → $18 | Maintains | Neutral | Get Alert | |
| 05/11/2026 | IMA | Buy Now | ImageneBio | $5.39 | -62.89% | $2 → $2 | Reiterates | Underperform → Underperform | Get Alert | |
| 05/11/2026 | NKTR | Buy Now | Nektar Therapeutics | $69.09 | 15.79% | $95 → $80 | Maintains | Neutral | Get Alert | |
| 05/11/2026 | ARTV | Buy Now | Artiva Biotherapeutics | $9.46 | 322.83% | $23 → $40 | Maintains | Outperform | Get Alert | |
| 05/01/2026 | RNAC | Buy Now | Cartesian Therapeutics | $7.38 | 414.91% | $38 → $38 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/29/2026 | ACRS | Buy Now | Aclaris Therapeutics | $4.35 | 129.89% | $8 → $10 | Maintains | Outperform | Get Alert | |
| 04/21/2026 | NKTR | Buy Now | Nektar Therapeutics | $69.09 | 37.5% | $70 → $95 | Maintains | Neutral | Get Alert | |
| 04/15/2026 | ORKA | Buy Now | Oruka Therapeutics | $60.10 | 41.43% | $45 → $85 | Maintains | Outperform | Get Alert | |
| 04/14/2026 | SANA | Buy Now | Sana Biotechnology | $3.06 | 129.13% | $6 → $7 | Maintains | Outperform | Get Alert | |
| 03/31/2026 | VOR | Buy Now | Vor Biopharma | $14.16 | 5.93% | $9 → $15 | Maintains | Neutral | Get Alert | |
| 03/31/2026 | ACRS | Buy Now | Aclaris Therapeutics | $4.35 | 83.91% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/24/2026 | NKTR | Buy Now | Nektar Therapeutics | $69.09 | 1.32% | → $70 | Initiates | → Neutral | Get Alert | |
| 03/13/2026 | ORKA | Buy Now | Oruka Therapeutics | $60.10 | -25.12% | $45 → $45 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/12/2026 | ANAB | Buy Now | AnaptysBio | $61.44 | 22.07% | $60 → $75 | Maintains | Outperform | Get Alert | |
| 03/10/2026 | RNAC | Buy Now | Cartesian Therapeutics | $7.38 | 414.91% | $38 → $38 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/09/2026 | ZURA | Buy Now | Zura Bio | $4.59 | 226.8% | → $15 | Initiates | → Outperform | Get Alert | |
| 01/13/2026 | ORKA | Buy Now | Oruka Therapeutics | $60.10 | -25.12% | $42 → $45 | Maintains | Outperform | Get Alert | |
| 12/22/2025 | ZBIO | Buy Now | Zenas BioPharma | $18.05 | 149.24% | $45 → $45 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/25/2025 | VOR | Buy Now | Vor Biopharma | $14.16 | -36.44% | → $9 | Assumes | → Neutral | Get Alert | |
| 11/25/2025 | IMA | Buy Now | ImageneBio | $5.39 | -62.89% | → $2 | Assumes | → Underperform | Get Alert | |
| 11/24/2025 | ANAB | Buy Now | AnaptysBio | $61.44 | -18.62% | $50 → $50 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/07/2025 | SANA | Buy Now | Sana Biotechnology | $3.06 | 96.4% | $5 → $6 | Maintains | Outperform | Get Alert | |
| 10/17/2025 | ARTV | Buy Now | Artiva Biotherapeutics | $9.46 | 143.13% | $18 → $23 | Maintains | Outperform | Get Alert | |
| 10/15/2025 | ANAB | Buy Now | AnaptysBio | $61.44 | 13.93% | $45 → $70 | Maintains | Outperform | Get Alert | |
| 10/09/2025 | ZBIO | Buy Now | Zenas BioPharma | $18.05 | 121.55% | $35 → $40 | Maintains | Outperform | Get Alert | |
| 09/30/2025 | ANAB | Buy Now | AnaptysBio | $61.44 | -26.76% | $45 → $45 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/24/2025 | SANA | Buy Now | Sana Biotechnology | $3.06 | 63.67% | → $5 | Initiates | → Outperform | Get Alert | |
| 08/07/2025 | ANAB | Buy Now | AnaptysBio | $61.44 | -26.76% | $40 → $45 | Maintains | Outperform | Get Alert | |
| 07/09/2025 | RNAC | Buy Now | Cartesian Therapeutics | $7.38 | 414.91% | → $38 | Initiates | → Outperform | Get Alert | |
| 05/28/2025 | ACRS | Buy Now | Aclaris Therapeutics | $4.35 | 83.91% | → $8 | Initiates | → Outperform | Get Alert | |
| 05/15/2025 | ORKA | Buy Now | Oruka Therapeutics | $60.10 | -33.44% | $40 → $40 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/01/2025 | ANAB | Buy Now | AnaptysBio | $61.44 | -34.9% | $40 → $40 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/25/2025 | ARTV | Buy Now | Artiva Biotherapeutics | $9.46 | 90.27% | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/20/2025 | ZBIO | Buy Now | Zenas BioPharma | $18.05 | 93.85% | → $35 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved